Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease

M Møller-Hansen, AC Larsen, PB Toft, CD Lynggaard… - The ocular …, 2021 - Elsevier
Purpose To evaluate the safety and feasibility of injecting allogeneic adipose-derived
mesenchymal stem cells (ASCs) into the lacrimal gland (LG) as a treatment of aqueous …
被引用次数：49 相关文章

Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease

M Møller-Hansen, AC Larsen, PB Toft… - The ocular …, 2021 - research.regionh.dk
PURPOSE: To evaluate the safety and feasibility of injecting allogeneic adipose-derived
mesenchymal stem cells (ASCs) into the lacrimal gland (LG) as a treatment of aqueous …

Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease

M Møller-Hansen, AC Larsen, PB Toft… - The ocular …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate the safety and feasibility of injecting allogeneic adipose-derived
mesenchymal stem cells (ASCs) into the lacrimal gland (LG) as a treatment of aqueous …
[PDF] researchgate.net

[PDF][PDF] Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease

M Møller-Hansen, AC Larsen, PB Toft… - Ocular …, 2021 - researchgate.net
Purpose: To evaluate the safety and feasibility of injecting allogeneic adipose-derived
mesenchymal stem cells (ASCs) into the lacrimal gland (LG) as a treatment of aqueous …
[PDF] academia.edu

[PDF][PDF] Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease 2

M Møller-Hansen, AC Larsen, PB Toft… - academia.edu
Purpose: To evaluate the safety and feasibility of injecting allogeneic adipose-derived 27
mesenchymal stem cells (ASCs) into the lacrimal gland (LG) as a treatment of aqueous …

Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease

M Møller-Hansen, AC Larsen, PB Toft, CD Lynggaard… - ikm.ku.dk
Purpose: To evaluate the safety and feasibility of injecting allogeneic adipose-derived
mesenchymal stem cells (ASCs) into the lacrimal gland (LG) as a treatment of aqueous …

Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease.

M Møller-Hansen, AC Larsen, PB Toft… - The Ocular …, 2020 - europepmc.org
Purpose To evaluate the safety and feasibility of injecting allogeneic adipose-derived
mesenchymal stem cells (ASCs) into the lacrimal gland (LG) as a treatment of aqueous …